Inventor

Guaili Wu

Inventor

Jiangsu, CN

Overview

2016–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 14 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds24%

A61KPreparations for medical, dental or toiletry purposes22%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%

C07BGeneral methods of organic chemistry20%

C07CAcyclic or carbocyclic compounds6%

C07HSugars2%

H04WWireless communication networks2%

Y02PClimate change mitigation technologies in the production or processing of goods2%

PatentTitleYear

10,904,701Positioning information transmission method and communication device2021 10,793,548Method for preparing tyrosine kinase inhibitor and derivative thereof2020 10,626,116Crystalline form of BTK kinase inhibitor and preparation method thereof2020 10,358,424Sodium salt of uric acid transporter inhibitor and crystalline form thereof2019 10,301,344L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereof2019 10,196,361Sodium salt of uric acid transporter inhibitor and crystalline form thereof2019 10,160,759Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor2018 10,150,770Crystal form of bisulfate of JAK inhibitor and preparation method therefor2018 10,150,739Crystalline form of androgen receptor inhibitor and preparation method thereof2018 10,118,911P-toluenesulfonate for MEK kinase inhibitor, and crystal form thereof and preparation method therefor2018 10,030,018Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor2018 10,023,577Crystalline form of JAK kinase inhibitor bisulfate and a preparation method thereof2018 9,422,300'Bisulfate of janus kinase (JAK) inhibitor and preparation method therefor'2016 9,309,226'Crystalline form I of tyrosine kinase inhibitor dimaleate and preparation methods thereof'2016

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2016–2020Patents assigned to JIANGSU HENGRUI MEDICINE CO (13)· patent assignee history

2016–2020Based in Jiangsu, CN· patent location history

2018Patents assigned to JIANGSU HENGRUI CO LTD (1)· patent assignee history

2021Patents assigned to HYTERA COMM CORP LTD (1)· patent assignee history

2021Based in Shenzhen, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
JIANGSU HENGRUI MEDICINE CO	13	2016–2020
HYTERA COMM CORP LTD	1	2021
JIANGSU HENGRUI CO LTD	1	2018

Locations

Location	Patents	Span
Jiangsu, CN	13	2016–2020
Shenzhen, CN	1	2021